Medical Breaktrhough

A buildup of the peptide Amyloid beta is linked to Alzheimer’s disease, but how the blockage causes the disorder is unclear. A study led by Dr. Ryohei Yasuda at the Max Planck Florida Institute for Neuroscience (561-972-9000) found the presence of the peptide leads to higher levels of the signaling protein centaurin-a1, which appears to cause neuronal dysfunction. This finding could lead to new treatments blocking centa1’s pathway.